Global Viral Vectors Market Size, Status and Forecast 2024-2031

Report ID: 953075 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Viral Vectors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Retroviral Vectors
        1.2.3 Lentiviral Vectors
        1.2.4 Adenoviral Vectors
        1.2.5 Herpes Simplex Virus Vectors
        1.2.6 Chimeric Viral Vectors
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Viral Vectors Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancers
        1.3.3 Inherited Disorders
        1.3.4 Viral Infections
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Viral Vectors Market Perspective (2016-2027)
    2.2 Viral Vectors Growth Trends by Regions
        2.2.1 Viral Vectors Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Viral Vectors Historic Market Share by Regions (2016-2021)
        2.2.3 Viral Vectors Forecasted Market Size by Regions (2022-2027)
    2.3 Viral Vectors Industry Dynamic
        2.3.1 Viral Vectors Market Trends
        2.3.2 Viral Vectors Market Drivers
        2.3.3 Viral Vectors Market Challenges
        2.3.4 Viral Vectors Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Viral Vectors Players by Revenue
        3.1.1 Global Top Viral Vectors Players by Revenue (2016-2021)
        3.1.2 Global Viral Vectors Revenue Market Share by Players (2016-2021)
    3.2 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Viral Vectors Revenue
    3.4 Global Viral Vectors Market Concentration Ratio
        3.4.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2020
    3.5 Viral Vectors Key Players Head office and Area Served
    3.6 Key Players Viral Vectors Product Solution and Service
    3.7 Date of Enter into Viral Vectors Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vectors Breakdown Data by Type
    4.1 Global Viral Vectors Historic Market Size by Type (2016-2021)
    4.2 Global Viral Vectors Forecasted Market Size by Type (2022-2027)

5 Viral Vectors Breakdown Data by Application
    5.1 Global Viral Vectors Historic Market Size by Application (2016-2021)
    5.2 Global Viral Vectors Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Viral Vectors Market Size (2016-2027)
    6.2 North America Viral Vectors Market Size by Type
        6.2.1 North America Viral Vectors Market Size by Type (2016-2021)
        6.2.2 North America Viral Vectors Market Size by Type (2022-2027)
        6.2.3 North America Viral Vectors Market Size by Type (2016-2027)
    6.3 North America Viral Vectors Market Size by Application
        6.3.1 North America Viral Vectors Market Size by Application (2016-2021)
        6.3.2 North America Viral Vectors Market Size by Application (2022-2027)
        6.3.3 North America Viral Vectors Market Size by Application (2016-2027)
    6.4 North America Viral Vectors Market Size by Country
        6.4.1 North America Viral Vectors Market Size by Country (2016-2021)
        6.4.2 North America Viral Vectors Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Viral Vectors Market Size (2016-2027)
    7.2 Europe Viral Vectors Market Size by Type
        7.2.1 Europe Viral Vectors Market Size by Type (2016-2021)
        7.2.2 Europe Viral Vectors Market Size by Type (2022-2027)
        7.2.3 Europe Viral Vectors Market Size by Type (2016-2027)
    7.3 Europe Viral Vectors Market Size by Application
        7.3.1 Europe Viral Vectors Market Size by Application (2016-2021)
        7.3.2 Europe Viral Vectors Market Size by Application (2022-2027)
        7.3.3 Europe Viral Vectors Market Size by Application (2016-2027)
    7.4 Europe Viral Vectors Market Size by Country
        7.4.1 Europe Viral Vectors Market Size by Country (2016-2021)
        7.4.2 Europe Viral Vectors Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Viral Vectors Market Size (2016-2027)
    8.2 Asia-Pacific Viral Vectors Market Size by Type
        8.2.1 Asia-Pacific Viral Vectors Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Viral Vectors Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Viral Vectors Market Size by Type (2016-2027)
    8.3 Asia-Pacific Viral Vectors Market Size by Application
        8.3.1 Asia-Pacific Viral Vectors Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Viral Vectors Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Viral Vectors Market Size by Application (2016-2027)
    8.4 Asia-Pacific Viral Vectors Market Size by Region
        8.4.1 Asia-Pacific Viral Vectors Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Viral Vectors Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Viral Vectors Market Size (2016-2027)
    9.2 Latin America Viral Vectors Market Size by Type
        9.2.1 Latin America Viral Vectors Market Size by Type (2016-2021)
        9.2.2 Latin America Viral Vectors Market Size by Type (2022-2027)
        9.2.3 Latin America Viral Vectors Market Size by Type (2016-2027)
    9.3 Latin America Viral Vectors Market Size by Application
        9.3.1 Latin America Viral Vectors Market Size by Application (2016-2021)
        9.3.2 Latin America Viral Vectors Market Size by Application (2022-2027)
        9.3.3 Latin America Viral Vectors Market Size by Application (2016-2027)
    9.4 Latin America Viral Vectors Market Size by Country
        9.4.1 Latin America Viral Vectors Market Size by Country (2016-2021)
        9.4.2 Latin America Viral Vectors Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Viral Vectors Market Size (2016-2027)
    10.2 Middle East & Africa Viral Vectors Market Size by Type
        10.2.1 Middle East & Africa Viral Vectors Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Viral Vectors Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Viral Vectors Market Size by Type (2016-2027)
    10.3 Middle East & Africa Viral Vectors Market Size by Application
        10.3.1 Middle East & Africa Viral Vectors Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Viral Vectors Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Viral Vectors Market Size by Application (2016-2027)
    10.4 Middle East & Africa Viral Vectors Market Size by Country
        10.4.1 Middle East & Africa Viral Vectors Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Viral Vectors Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 BioReliance
        11.1.1 BioReliance Company Details
        11.1.2 BioReliance Business Overview
        11.1.3 BioReliance Viral Vectors Introduction
        11.1.4 BioReliance Revenue in Viral Vectors Business (2016-2021)
        11.1.5 BioReliance Recent Development
    11.2 Cobra Biologics
        11.2.1 Cobra Biologics Company Details
        11.2.2 Cobra Biologics Business Overview
        11.2.3 Cobra Biologics Viral Vectors Introduction
        11.2.4 Cobra Biologics Revenue in Viral Vectors Business (2016-2021)
        11.2.5 Cobra Biologics Recent Development
    11.3 Oxford BioMedica
        11.3.1 Oxford BioMedica Company Details
        11.3.2 Oxford BioMedica Business Overview
        11.3.3 Oxford BioMedica Viral Vectors Introduction
        11.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2016-2021)
        11.3.5 Oxford BioMedica Recent Development
    11.4 UniQure
        11.4.1 UniQure Company Details
        11.4.2 UniQure Business Overview
        11.4.3 UniQure Viral Vectors Introduction
        11.4.4 UniQure Revenue in Viral Vectors Business (2016-2021)
        11.4.5 UniQure Recent Development
    11.5 FinVector
        11.5.1 FinVector Company Details
        11.5.2 FinVector Business Overview
        11.5.3 FinVector Viral Vectors Introduction
        11.5.4 FinVector Revenue in Viral Vectors Business (2016-2021)
        11.5.5 FinVector Recent Development
    11.6 MolMed
        11.6.1 MolMed Company Details
        11.6.2 MolMed Business Overview
        11.6.3 MolMed Viral Vectors Introduction
        11.6.4 MolMed Revenue in Viral Vectors Business (2016-2021)
        11.6.5 MolMed Recent Development
    11.7 MassBiologics
        11.7.1 MassBiologics Company Details
        11.7.2 MassBiologics Business Overview
        11.7.3 MassBiologics Viral Vectors Introduction
        11.7.4 MassBiologics Revenue in Viral Vectors Business (2016-2021)
        11.7.5 MassBiologics Recent Development
    11.8 Richter-Helm
        11.8.1 Richter-Helm Company Details
        11.8.2 Richter-Helm Business Overview
        11.8.3 Richter-Helm Viral Vectors Introduction
        11.8.4 Richter-Helm Revenue in Viral Vectors Business (2016-2021)
        11.8.5 Richter-Helm Recent Development
    11.9 FUJIFILM Diosynth Biotechnologies
        11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
        11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction
        11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2016-2021)
        11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
    11.10 Lonza
        11.10.1 Lonza Company Details
        11.10.2 Lonza Business Overview
        11.10.3 Lonza Viral Vectors Introduction
        11.10.4 Lonza Revenue in Viral Vectors Business (2016-2021)
        11.10.5 Lonza Recent Development
    11.11 Aldevron
        11.11.1 Aldevron Company Details
        11.11.2 Aldevron Business Overview
        11.11.3 Aldevron Viral Vectors Introduction
        11.11.4 Aldevron Revenue in Viral Vectors Business (2016-2021)
        11.11.5 Aldevron Recent Development
    11.12 Eurogentec
        11.12.1 Eurogentec Company Details
        11.12.2 Eurogentec Business Overview
        11.12.3 Eurogentec Viral Vectors Introduction
        11.12.4 Eurogentec Revenue in Viral Vectors Business (2016-2021)
        11.12.5 Eurogentec Recent Development
    11.13 Cell and Gene Therapy Catapult
        11.13.1 Cell and Gene Therapy Catapult Company Details
        11.13.2 Cell and Gene Therapy Catapult Business Overview
        11.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction
        11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2016-2021)
        11.13.5 Cell and Gene Therapy Catapult Recent Development
    11.14 Biovian
        11.14.1 Biovian Company Details
        11.14.2 Biovian Business Overview
        11.14.3 Biovian Viral Vectors Introduction
        11.14.4 Biovian Revenue in Viral Vectors Business (2016-2021)
        11.14.5 Biovian Recent Development
    11.15 Thermo Fisher Scientific (Brammer Bio)
        11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
        11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
        11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Introduction
        11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2016-2021)
        11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
    11.16 VGXI
        11.16.1 VGXI Company Details
        11.16.2 VGXI Business Overview
        11.16.3 VGXI Viral Vectors Introduction
        11.16.4 VGXI Revenue in Viral Vectors Business (2016-2021)
        11.16.5 VGXI Recent Development
    11.17 PlasmidFactory
        11.17.1 PlasmidFactory Company Details
        11.17.2 PlasmidFactory Business Overview
        11.17.3 PlasmidFactory Viral Vectors Introduction
        11.17.4 PlasmidFactory Revenue in Viral Vectors Business (2016-2021)
        11.17.5 PlasmidFactory Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Viral Vectors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Retroviral Vectors
    Table 3. Key Players of Lentiviral Vectors
    Table 4. Key Players of Adenoviral Vectors
    Table 5. Key Players of Herpes Simplex Virus Vectors
    Table 6. Key Players of Chimeric Viral Vectors
    Table 7. Key Players of Others
    Table 8. Global Viral Vectors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Viral Vectors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Viral Vectors Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Viral Vectors Market Share by Regions (2016-2021)
    Table 12. Global Viral Vectors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Viral Vectors Market Share by Regions (2022-2027)
    Table 14. Viral Vectors Market Trends
    Table 15. Viral Vectors Market Drivers
    Table 16. Viral Vectors Market Challenges
    Table 17. Viral Vectors Market Restraints
    Table 18. Global Viral Vectors Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Viral Vectors Market Share by Players (2016-2021)
    Table 20. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors as of 2020)
    Table 21. Ranking of Global Top Viral Vectors Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Viral Vectors Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Viral Vectors Product Solution and Service
    Table 25. Date of Enter into Viral Vectors Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Viral Vectors Revenue Market Share by Type (2016-2021)
    Table 29. Global Viral Vectors Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Viral Vectors Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Viral Vectors Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Viral Vectors Revenue Market Share by Application (2016-2021)
    Table 33. Global Viral Vectors Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Viral Vectors Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Viral Vectors Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Viral Vectors Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Viral Vectors Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Viral Vectors Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Viral Vectors Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Viral Vectors Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Viral Vectors Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Viral Vectors Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Viral Vectors Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Viral Vectors Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Viral Vectors Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Viral Vectors Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Viral Vectors Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Viral Vectors Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Viral Vectors Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Viral Vectors Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Viral Vectors Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Viral Vectors Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Viral Vectors Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Viral Vectors Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Viral Vectors Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Viral Vectors Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Viral Vectors Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Viral Vectors Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Viral Vectors Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Viral Vectors Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. BioReliance Company Details
    Table 66. BioReliance Business Overview
    Table 67. BioReliance Viral Vectors Product
    Table 68. BioReliance Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 69. BioReliance Recent Development
    Table 70. Cobra Biologics Company Details
    Table 71. Cobra Biologics Business Overview
    Table 72. Cobra Biologics Viral Vectors Product
    Table 73. Cobra Biologics Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 74. Cobra Biologics Recent Development
    Table 75. Oxford BioMedica Company Details
    Table 76. Oxford BioMedica Business Overview
    Table 77. Oxford BioMedica Viral Vectors Product
    Table 78. Oxford BioMedica Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 79. Oxford BioMedica Recent Development
    Table 80. UniQure Company Details
    Table 81. UniQure Business Overview
    Table 82. UniQure Viral Vectors Product
    Table 83. UniQure Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 84. UniQure Recent Development
    Table 85. FinVector Company Details
    Table 86. FinVector Business Overview
    Table 87. FinVector Viral Vectors Product
    Table 88. FinVector Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 89. FinVector Recent Development
    Table 90. MolMed Company Details
    Table 91. MolMed Business Overview
    Table 92. MolMed Viral Vectors Product
    Table 93. MolMed Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 94. MolMed Recent Development
    Table 95. MassBiologics Company Details
    Table 96. MassBiologics Business Overview
    Table 97. MassBiologics Viral Vectors Product
    Table 98. MassBiologics Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 99. MassBiologics Recent Development
    Table 100. Richter-Helm Company Details
    Table 101. Richter-Helm Business Overview
    Table 102. Richter-Helm Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 103. Richter-Helm Recent Development
    Table 104. FUJIFILM Diosynth Biotechnologies Company Details
    Table 105. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 106. FUJIFILM Diosynth Biotechnologies Viral Vectors Product
    Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 108. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 109. Lonza Company Details
    Table 110. Lonza Business Overview
    Table 111. Lonza Viral Vectors Product
    Table 112. Lonza Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 113. Lonza Recent Development
    Table 114. Aldevron Company Details
    Table 115. Aldevron Business Overview
    Table 116. Aldevron Viral Vectors Product
    Table 117. Aldevron Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 118. Aldevron Recent Development
    Table 119. Eurogentec Company Details
    Table 120. Eurogentec Business Overview
    Table 121. Eurogentec Viral Vectors Product
    Table 122. Eurogentec Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 123. Eurogentec Recent Development
    Table 124. Cell and Gene Therapy Catapult Company Details
    Table 125. Cell and Gene Therapy Catapult Business Overview
    Table 126. Cell and Gene Therapy Catapult Viral Vectors Product
    Table 127. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 128. Cell and Gene Therapy Catapult Recent Development
    Table 129. Biovian Company Details
    Table 130. Biovian Business Overview
    Table 131. Biovian Viral Vectors Product
    Table 132. Biovian Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 133. Biovian Recent Development
    Table 134. Thermo Fisher Scientific (Brammer Bio) Company Details
    Table 135. Thermo Fisher Scientific (Brammer Bio) Business Overview
    Table 136. Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product
    Table 137. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 138. Thermo Fisher Scientific (Brammer Bio) Recent Development
    Table 139. VGXI Company Details
    Table 140. VGXI Business Overview
    Table 141. VGXI Viral Vectors Product
    Table 142. VGXI Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 143. VGXI Recent Development
    Table 144. PlasmidFactory Company Details
    Table 145. PlasmidFactory Business Overview
    Table 146. PlasmidFactory Viral Vectors Product
    Table 147. PlasmidFactory Revenue in Viral Vectors Business (2016-2021) & (US$ Million)
    Table 148. PlasmidFactory Recent Development
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vectors Market Share by Type: 2020 VS 2027
    Figure 2. Retroviral Vectors Features
    Figure 3. Lentiviral Vectors Features
    Figure 4. Adenoviral Vectors Features
    Figure 5. Herpes Simplex Virus Vectors Features
    Figure 6. Chimeric Viral Vectors Features
    Figure 7. Others Features
    Figure 8. Global Viral Vectors Market Share by Application: 2020 VS 2027
    Figure 9. Cancers Case Studies
    Figure 10. Inherited Disorders Case Studies
    Figure 11. Viral Infections Case Studies
    Figure 12. Others Case Studies
    Figure 13. Viral Vectors Report Years Considered
    Figure 14. Global Viral Vectors Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Viral Vectors Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Viral Vectors Market Share by Regions: 2020 VS 2027
    Figure 17. Global Viral Vectors Market Share by Regions (2022-2027)
    Figure 18. Global Viral Vectors Market Share by Players in 2020
    Figure 19. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2020
    Figure 21. Global Viral Vectors Revenue Market Share by Type (2016-2021)
    Figure 22. Global Viral Vectors Revenue Market Share by Type (2022-2027)
    Figure 23. North America Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Viral Vectors Market Share by Type (2016-2027)
    Figure 25. North America Viral Vectors Market Share by Application (2016-2027)
    Figure 26. North America Viral Vectors Market Share by Country (2016-2027)
    Figure 27. United States Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Viral Vectors Market Share by Type (2016-2027)
    Figure 31. Europe Viral Vectors Market Share by Application (2016-2027)
    Figure 32. Europe Viral Vectors Market Share by Country (2016-2027)
    Figure 33. Germany Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Viral Vectors Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Viral Vectors Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Viral Vectors Market Share by Region (2016-2027)
    Figure 43. China Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Viral Vectors Market Share by Type (2016-2027)
    Figure 51. Latin America Viral Vectors Market Share by Application (2016-2027)
    Figure 52. Latin America Viral Vectors Market Share by Country (2016-2027)
    Figure 53. Mexico Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Viral Vectors Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Viral Vectors Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Viral Vectors Market Share by Country (2016-2027)
    Figure 59. Turkey Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Viral Vectors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. BioReliance Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 63. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 64. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 65. UniQure Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 66. FinVector Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 67. MolMed Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 68. MassBiologics Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 69. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 70. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 71. Lonza Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 72. Aldevron Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 73. Eurogentec Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 74. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 75. Biovian Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 76. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 77. VGXI Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 78. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2016-2021)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Frequently Asked Questions
Viral Vectors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Viral Vectors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Viral Vectors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Film Soundtracks

Market Analysis and Insights: Global Film Soundtracks Market
The global Film Soundt ... Read More